METRONOMIC ORAL CYCLOPHOSPHAMIDE IN THE SALVAGE TREATMENT OF HEAVILY TREATED OVARIAN CANCER PATIENTS: A RETROSPECTIVE, MULTICENTER STUDY

被引：0
|
作者：
Corrado, G. [1 ]
Mascilini, F. [2 ]
Savarese, A. [3 ]
Samaritani, R. [4 ]
Salutari, V. [2 ]
Di Stefano, M. [2 ]
Malaguti, P. [3 ]
Vizza, E. [1 ]
Scambia, G. [2 ]
Ferrandina, G. [2 ]
机构：
[1] Regina Elena Inst Canc Res, Gynecol Oncol Unit, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Gynecol Oncol Unit, I-00168 Rome, Italy
[3] Regina Elena Inst Canc Res, Med Oncol Unit, Rome, Italy
[4] Regina Margherita Hosp, Med Oncol Unit, Rome, Italy
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
    Gabriella Ferrandina
    Giacomo Corrado
    Floriana Mascilini
    Paola Malaguti
    Riccardo Samaritani
    Mariagrazia Distefano
    Valeria Masciullo
    Alessia Di Legge
    Antonella Savarese
    Giovanni Scambia
    BMC Cancer, 14
  • [2] Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
    Ferrandina, Gabriella
    Corrado, Giacomo
    Mascilini, Floriana
    Malaguti, Paola
    Samaritani, Riccardo
    Distefano, Mariagrazia
    Masciullo, Valeria
    Di Legge, Alessia
    Savarese, Antonella
    Scambia, Giovanni
    BMC CANCER, 2014, 14
  • [3] Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: A retrospective, multicenter study
    Ferrandina, Gabriella
    Salutari, Vanda
    Vincenzi, Bruno
    Marinaccio, Marco
    Naglieri, Emanuele
    Loizzi, Vera
    Carpano, Silvia
    Amadio, Giulia
    Tonini, Giuseppe
    Scambia, Giovanni
    Lorusso, Domenica
    GYNECOLOGIC ONCOLOGY, 2013, 130 (03) : 505 - 510
  • [4] Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer
    Watanabe, Yoh
    Etoh, Tomomaro
    Koike, Eiji
    Mizuno, Yoshiaki
    Wang, Wei-Min
    Hoshiai, Hiroshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (05) : 468 - 471
  • [5] Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer
    Yoh Watanabe
    Tomomaro Etoh
    Eiji Koike
    Yoshiaki Mizuno
    Wei-Min Wang
    Hiroshi Hoshiai
    International Journal of Clinical Oncology, 2010, 15 : 468 - 471
  • [6] Metronomic oral cyclophosphamide in relapsed ovarian cancer
    Spiliopoulou, Pavlina
    Hinsley, Samantha
    McNeish, Iain A.
    Roxburgh, Patricia
    Glasspool, Ros
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (07) : 1037 - 1044
  • [7] Bevacizumab plus Low-Dose Metronomic Oral Cyclophosphamide in Heavily Pretreated Patients with Recurrent Ovarian Cancer
    Sanchez-Munoz, Alfonso
    Mendiola, Cesar
    Perez-Ruiz, Elisabeth
    Rodriguez-Sanchez, Cesar A.
    Miguel Jurado, Jose
    Alonso-Carrion, Lorenzo
    Ghanem, Ismael
    de Velasco, Guillermo
    Quero-Blanco, Cristina
    Alba, Emilio
    ONCOLOGY, 2010, 79 (1-2) : 98 - 104
  • [8] CLINICAL BENEFIT OF ORAL METRONOMIC CYCLOPHOSPHAMIDE ADMINISTRATION IN HEAVILY PRETREATED RECURRENT EPITHELIAL OVARIAN CANCER
    Attianese, D.
    Badellino, E.
    Villa, M.
    Bellero, M.
    Massobrio, R.
    Fuso, L.
    Biglia, N.
    Ferrero, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A230 - A230
  • [9] Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Merla, Emanuela
    Ballerini, Filippo
    Fabbri, Alberto
    Guarini, Attilio
    Pavone, Vincenzo
    Quintini, Gerlando
    Puccini, Benedetta
    Vigliotti, Maria Luigia
    Stefoni, Vittorio
    Derenzini, Enrico
    Broccoli, Alessandro
    Gandolfi, Letizia
    Quirini, Federica
    Casadei, Beatrice
    Argnani, Lisa
    Baccarani, Michele
    HEMATOLOGICAL ONCOLOGY, 2013, 31 (04) : 179 - 182
  • [10] Efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of platinum resistant recurrent ovarian cancer: A retrospective observational study
    Steck, Alexandra
    Barlin, Joyce
    Timmins, Patrick
    McElrath, Timothy
    Martin, Jovana
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S244 - S244
12345